Learn more

CHROMADEX INC

Overview
  • Total Patents
    84
  • GoodIP Patent Rank
    23,192
  • Filing trend
    ⇩ 88.0%
About

CHROMADEX INC has a total of 84 patent applications. It decreased the IP activity by 88.0%. Its first patent ever was published in 2012. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and foods and drinks are BENEBIOSIS CO LTD, HYBEN VITAL LICENS APS and HONEYLAB LTD.

Patent filings per year

Chart showing CHROMADEX INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Rhonemus Troy 47
#2 Dellinger Ryan 38
#3 Redpath Philip 27
#4 Migaud Marie Eugenie 24
#5 Cunningham Richard 23
#6 Bartos Jeremy 20
#7 Crossey Kerri 14
#8 Morris Mark 14
#9 Venkataraman Sylesh 13
#10 Erickson Aron 12

Latest patents

Publication Filing date Title
US2020268778A1 Use of nicotinamide riboside, nicotinic acid riboside, reduced nicotinyl riboside compounds, and nicotinyl riboside compound derivatives in formulations
US2020181188A1 Crystalline forms of nicotinoyl ribosides and derivatives thereof, and methods of preparation thereof
US2017304338A1 Use of nicotinic acid riboside or nicotinamide riboside derivatives, and reduced derivatives thereof, as NAD+ increasing precursors
US2017296564A1 Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucleotide, reduced nicotinyl compounds, and nicotinoyl compound derivatives in infant formula for healthy development
AU2017232930A1 B-vitamin and amino acid conjugates of nicotinoyl ribosides and reduced nicotinoyl ribosides, derivatives thereof, and methods of preparation thereof
CN107846883A The solvent-free phosphorylation of selectivity
MX2017011851A Nicotinic acid riboside or nicotinamide riboside compositions, reduced derivatives thereof, and the use thereof.
CN105873937A Nicotinamide riboside compositions for topical use in treating skin conditions
US2013296440A1 Pterostilbene and curcumin combination for treatment of oxidative stress and inflammation
US2013149277A1 Pterostilbene and pvp grape juice extract combination for treatment of metabolic, vascular, and neurodegenerative disorders
KR20150027081A Method for inducing udp-glucuronosyltransferase activity using pterostilbene
AU2012308222A1 Pterostilbene and statin combination for treatment of metabolic disease, cardiovascular disease, and inflammation